Nurix Therapeutics Inc (NAS:NRIX)
$ 25.22 +0.090 (+0.36%) Market Cap: 2.62 Bil Enterprise Value: 2.23 Bil PE Ratio: 0 PB Ratio: 6.49 GF Score: 61/100

Nurix Therapeutics Inc Annual Shareholders Meeting Transcript

May 15, 2026 / 04:00PM GMT
Release Date Price: $15.86 (-0.91%)
Arthur T. Sands
Nurix Therapeutics Inc - President, Chief Executive Officer, and Board Director

Good morning.

This is Arthur Sands, President and Chief Executive Officer of Nurix Therapeutics. I'd like to welcome you to Nurix's 2026 Annual Meeting of Stockholders. It's 9 a.m. Pacific Time on May 15, 2026, and this meeting is officially called to order.

This is our agenda for today's meeting. First, I will introduce our independent auditors and our inspector of elections, and then I will review the legal requirements for conducting business at this meeting.

I will then open the polls for voting and introduce the items of business at this meeting, which are listed briefly here as Agenda Item 3.

During voting, I will give a short presentation on Nurix's key achievements and progress over the past year. I will then close the polls and provide preliminary voting results.

Finally, we will conclude with a brief Q&A session.

Stockholders may submit a question by typing it in the Ask a Question section at the bottom of your screen.

We will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot